| 1 |
Bevacizumab
💬
(Bevacizumab (USAN), Bevacizumab (genetical recombination) (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN), Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN), Bevacizumab-awwb, Bevacizumab-bvzr, Bevacizumab-maly, Bevacizumab-adcd, Bevacizumab-tnjn, Bevacizumab-nwgd) | [1] Bevacizumab Bevacizumab (Bevacizumab) | [1] Bevacizumab Bevacizumab | [1] VEGFA VEGFA 💬
| [23] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [8] 13 13, 34, 85, 87, 89, 227, 280, 331 💬
|
